Thursday, November 12, 2026

Global Markets Surge as Fed Signals Rate Stability and Washington Averts Shutdown

Major stock indices across the Americas, Europe, and Asia rallied November 11, 2025, after Federal Reserve official Mary Daly indicated inflation remains contained and U.S. lawmakers struck a deal to prevent government shutdown. Technology stocks led gains globally as investors shifted to risk-on positioning.

ViaNews Editorial Team

February 28, 2026

Source Trace Score1 source document1 with a live linkVerifiability: Basic
Global Markets Surge as Fed Signals Rate Stability and Washington Averts Shutdown
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

Stock markets worldwide posted sharp gains November 11, 2025, as Federal Reserve Bank of San Francisco President Mary Daly said tariff effects "have largely been confined to goods, with little spillover into services inflation" and inflation expectations remain "well-anchored around our 2% target."

Daly warned against "holding on too long to high interest rates only to find out we've injured the economy," citing a "labor market that's softening and wage growth that is moderating." The remarks eased concerns about aggressive Fed tightening, triggering gains across American, European, and Asian bourses.

A bipartisan U.S. government funding agreement backed by the White House further reduced political risk. The dual catalysts drove technology stocks higher, with AI semiconductor manufacturers leading the advance across markets from New York to Frankfurt to Tokyo.

The rally contrasted with earlier 2025 volatility when investors feared tariff-driven inflation would force the Fed to maintain restrictive policy longer. Services inflation stability proved critical, as services dominate most developed economies including the U.S., UK, and eurozone nations.

Global investors interpreted Daly's comments as confirmation the Fed has contained inflation without triggering recession through overly tight policy. Markets from London's FTSE to Hong Kong's Hang Seng responded positively to reduced uncertainty around U.S. monetary policy, which influences central bank decisions worldwide.

Technology sector strength demonstrated continued international confidence in AI and semiconductor growth despite economic headwinds. The sector outperformed across regions, suggesting investors globally view tech as resilient when backed by fundamental demand.

The simultaneous reduction in monetary policy and political risks created conditions for broad equity gains across developed markets. Risk appetite returned as key uncertainty factors diminished, with emerging markets also participating in the rally on improved global sentiment.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score1 source document1 with a live linkVerifiability: Basic
  1. [1]News articleNasdaq· November 10, 2025
    Stocks Finish Sharply Higher on Plans to Reopen the US Government

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com